Fact CheckerSign in

NCT07789795Recruiting

Hemodynamic Effects of Bilateral and Unilateral Spinal Anesthesia Using the Continuous Pressure Recording Analytical Method.

Comparison of the Hemodynamic Effects of Bilateral and Unilateral Spinal Anesthesia in Hip Arthroplasty Surgeries in Elderly Patients Using the Continuous Pressure Recording Analytical Method.

Source: ClinicalTrials.gov · Last updated 27 Aug 2026

Brief summary (registry, in English)

This randomized controlled study aims to compare the intraoperative hemodynamic effects of unilateral and bilateral spinal anesthesia in elderly patients undergoing elective total hip arthroplasty. Seventy-four patients aged 65 years and older will be randomized into two groups: unilateral spinal anesthesia (n=37) and bilateral spinal anesthesia (n=37). Hemodynamic parameters including cardiac output, stroke volume, stroke volume variation, pulse pressure variation, and systemic vascular resistance will be continuously monitored using the Pressure Recording Analytical Method (PRAM)-based MostCare monitoring system. Intraoperative fluid requirements and vasopressor consumption will also be evaluated. The study seeks to determine whether unilateral spinal anesthesia provides greater hemodynamic stability and reduces the need for fluid administration and vasopressor support compared with conventional bilateral spinal anesthesia in elderly patients undergoing hip arthroplasty.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
74 (estimated)
First submitted
11 Jun 2026
Start date
1 May 2026
Primary completion date
31 Aug 2026
Lead sponsor
Kayseri City Hospital
Diseases
Stroke
NCT number
NCT07789795

What you commit to

  • Study type: Interventional
  • Planned participants: 74
  • From 1 May 2026 to the primary completion date, 31 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of previous major neurosurgical intervention.
  • Severe spinal deformity (e.g., severe scoliosis, previous spinal fusion surgery, or spinal trauma).

Other illness

  • Anatomical abnormality, vascular defect, or infection at the site intended for arterial catheter placement for PRAM monitoring.
  • Presence of skin infection or systemic infection/sepsis.
  • Severe hypovolemia or decompensated cardiac disease in which spinal anesthesia is contraindicated.
  • Known allergy or hypersensitivity to local anesthetics or sedative agents.
  • Local infection or wound at the planned spinal puncture site.

Lab values

  • Current anticoagulant therapy or coagulopathy (INR \>1.5 or platelet count \<75,000/mm³).

Age

  • Age below 65 years.

Other

  • Glasgow Coma Scale (GCS) score \<13.
  • Clinical contraindication to spinal anesthesia (e.g., increased intracranial pressure, septicemia, or severe hypotension). -

Who the study is looking for

  • Adults aged 65 years and older.
  • Patients scheduled for elective total hip arthroplasty.
  • Patients with an American Society of Anesthesiologists (ASA) physical status classification of II, III, or IV.
  • Patients with a Glasgow Coma Scale (GCS) score of 13-15 who are conscious and able to cooperate.
  • Patients with suitable peripheral arterial anatomy for PRAM monitoring.
  • Patients who provide written informed consent to participate in the study.
  • Patients without any clinical contraindication to spinal anesthesia. -

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kayseri City Hospital
Coordinator of this site? Confirm its status
KayseriTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.